Home › Calculator › SMDPY Dividend Calculator 2026
SMDPY Dividend DRIP Calculator 2026
21.51% YieldHealthcareSumitomo Pharma Co., Ltd. · OTC
Price: $9.30 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SMDPY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SMDPY snowball 📈
$10,000 in SMDPY → $6.3K in 10 years · $0.22/month
About Sumitomo Pharma Co., Ltd. (SMDPY) — Dividend Analysis 2026
Sumitomo Pharma Co., Ltd. operates as a global entity focused on the development, manufacturing, and distribution of a diverse range of products. Its primary offerings include pharmaceutical drugs, food components and additives, and veterinary treatments. The company's reach extends across Japan, North America, China, and various other international markets. The pharmaceutical segment boasts an extensive portfolio addressing numerous medical conditions. This encompasses therapeutic agents for neurological disorders like Parkinson's disease and epilepsy, psychiatric conditions such as depression and atypical psychosis, and metabolic challenges including type 2 diabetes. Sumitomo Pharma also produces medications for cardiovascular diseases (e.g., hypertension, angina pectoris, arrhythmia), urological problems (such as overactive bladder and advanced prostate cancer), and other ailments like uterine fibroids, systemic fungal infections, pruritus, and chronic obstructive pulmonary disease (COPD). Additionally, it develops specialized treatments, including cultured thymus tissue for pediatric congenital athymia, drugs for rare diseases like Fabry disease, and carbapenem antibiotics. Beyond its core pharmaceutical operations, the company provides food-related products, specifically polysaccharides and various seasonings, including soups and bouillons. Its chemical product materials division serves multiple industries by supplying pharmaceutical excipients, ingredients for personal care products, coatings and industrial materials, and electronic materials. The company's veterinary division is dedicated to formulating and distributing medications for both household pets, such as dogs and cats, and a broad spectrum of livestock, including cattle, pigs, poultry, horses, and aquacultured fish. To drive innovation and expand its capabilities, Sumitomo Pharma engages in numerous strategic collaborations. It maintains partnerships with entities like Healios K.K., Keio University, RIKEN, the Center for iPS Cell Research and Application, Kyoto University, and Aikomi Co., Ltd. Key agreements also include a joint development initiative with SanBio Company Limited and a collaboration and licensing deal with Otsuka Pharmaceutical Co., Ltd. Furthermore, the company has formed a strategic alliance with Roivant Sciences Ltd. Sumitomo Pharma Co., Ltd. was established in Osaka, Japan, in 1897. The company, formerly known as Sumitomo Dainippon Pharma Co., Ltd., officially changed its name to Sumitomo Pharma Co., Ltd. in April 2022. It operates as a subsidiary of Sumitomo Chemical Company, Limited.
Compare SMDPY with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SMDPY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SMDPY position with:
🌍 SMDPY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SMDPY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 21.51% | 18.71% | $2,151 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 18.28% | 15.48% | $1,828 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 17.21% | 14.41% | $1,721 / yr |
| 🇬🇧 UK ISA | 0% | 21.51% | 18.71% | $2,151 / yr |
| 🇬🇧 UK Taxable | 8.75% | 19.63% | 16.83% | $1,963 / yr |
| 🇨🇦 TFSA | 0% | 21.51% | 18.71% | $2,151 / yr |
| 🇨🇦 CA Taxable | 25% | 16.13% | 13.33% | $1,613 / yr |
| 🇦🇺 Super (pension) | 15% | 18.28% | 15.48% | $1,828 / yr |
| 🇦🇺 AU Taxable | 30% | 15.06% | 12.26% | $1,506 / yr |
| 🇩🇪 DE Taxable | 26.375% | 15.84% | 13.04% | $1,584 / yr |
| 🇫🇷 FR Taxable | 30% | 15.06% | 12.26% | $1,506 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SMDPY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SMDPY Dividend Payment Schedule
SMDPY pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SMDPY vs Healthcare Benchmarks
How SMDPY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SMDPY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SMDPY Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SMDPY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Sumitomo Pharma Co., Ltd. (SMDPY) is currently trading at $9.30, 38% below its 52-week high. The current dividend yield is 21.51% based on an annual payout of $2.00 per share.
SMDPY (Sumitomo Pharma Co., Ltd.) — 21.51% Dividend Yield Analysis
Sumitomo Pharma Co., Ltd. (SMDPY) is a healthcare stock currently trading at $9.30 with a dividend yield of 21.51%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, SMDPY has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (21.51%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SMDPY News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.